1. The Role of the Urokinase-Type Plasminogen Activator System In Tumor Progression
   E. V. Kugaevskaya et al, 2019, Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry CrossRef
2. Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
   Gary Tincknell et al, 2021, Cancers CrossRef
3. Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα
   Hai Li et al, 2018, Integrative Cancer Therapies CrossRef
4. The urokinase-type plasminogen activator system and its role in tumor progression
   E.V. Kugaevskaya et al, 2018, Biomeditsinskaya Khimiya CrossRef
5. Adipocytes contribute to tumor progression and invasion of peritoneal metastasis by interacting with gastric cancer cells as cancer associated fibroblasts
   Toshihide Hamabe‐Horiike et al, 2023, Cancer Reports CrossRef
6. A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG
   Hui Shi et al, 2022, Clinical and Translational Oncology CrossRef
7. Probiotic Microorganism: A Promising and Innovative Tool for Cancer Prevention and Therapy
   Nabendu Debnath et al, 2021, Advances in Probiotics CrossRef
8. uPAR, beyond regulating physiological functions, has orchestrated roles in cancer (Review)
   Liang Wang et al, 2022, International Journal of Oncology CrossRef
9. Zyxin inhibits the epithelial–mesenchymal transition process in gastric cancer by upregulating SIRT1
   Jing Lou et al, 2023, MedComm CrossRef